Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factors

INTRODUCTION: The contribution of programmed cell death ligand-1 (PD-L1) immune checkpoint molecule toward progression of non-small cell lung cancer (NSCLC) has not yet been elucidated, in part, because of lack of a standardised method to evaluate PD-L1 expression. In this study, we developed a nove...

Descripción completa

Detalles Bibliográficos
Autores principales: Igarashi, Tomoyuki, Teramoto, Koji, Ishida, Mitsuaki, Hanaoka, Jun, Daigo, Yataro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070269/
https://www.ncbi.nlm.nih.gov/pubmed/27843633
http://dx.doi.org/10.1136/esmoopen-2016-000083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070269/
https://www.ncbi.nlm.nih.gov/pubmed/27843633
http://dx.doi.org/10.1136/esmoopen-2016-000083

Ejemplares similares